CBRE Group shares have gained 5.3% over the past four weeks to close at $134.69, but Wall Street analysts see further upside. The average 12-month price target from 12 analysts is $177, implying a potential gain of 31.4%. Targets range from $135 to $200, with a standard deviation of $16.7. Analysts have also been raising earnings estimates, with the Zacks Consensus Estimate for the current year increasing 0.3% over the last 30 days. CBRE currently holds a Zacks Rank #2, or Buy, suggesting near-term upside potential.
CBRE Group Inc Class AAnalyst price targets imply 31.4% upside and earnings estimates are being raised.